Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $224.84, with a market capitalization of 543.72B. The stock trades at a price-to-earnings (P/E) ratio of 26.08 and offers a dividend yield of 2.3%.
During the trading session on 2026-05-06, Johnson & Johnson(JNJ) shares reached a daily high of $226.34 and a low of $222.95. At a current price of $224.84, the stock is +0.8% higher than the low and still -0.7% under the high.
Trading volume for Johnson & Johnson(JNJ) stock has reached 7.98M, versus its average volume of 7.21M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $146.12.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $146.12.
JNJ News
There are plenty of dividend stocks on equity markets. Few are more secure than Dividend Kings, a group of corporations that have raised their payouts annually...
Key Points Johnson & Johnson is a Dividend King, with 64 consecutive years of increases. The company only spent 61% of its free cash flow in 2025 on dividend...
Johnson & Johnson's Ottava Robotic Surgical System has reported its first successful clinical outcomes in complex gastric bypass procedures. The system met pri...
Analyst ratings
61%
of 28 ratingsMore JNJ News
Put $5,000 Into This Dividend Giant and Earn Passive Income Every Quarter By Vandita Jadeja Published May 5, 10:50AM EDT Quick Read Johnson & Johnson (JNJ) ge...
Johnson & Johnson announced results from the Phase 3 FUZION study evaluating TREMFYA in adults with active perianal fistulizing Crohn’s disease. At Week 24, TRE...
Johnson & Johnson announced results from the first clinical study of the investigational OTTAVA Robotic Surgical System. The results were presented at the 2026...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Johnson & Johnson (JNJ) stock is drawing fresh attention after the FDA granted Priority Review to IMAAVY for warm autoimmune hemolytic anemia and approved a new...
In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US...
As the S&P 500 seeks the next leg higher, smart money might be moving toward healthcare, a sleeper sector of 2026. Still, the series of earnings upgrades, coupl...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.